Autolus Therapeutics
Autolus Therapeutics is a London-based biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases; its AUCATZYL CAR T therapy received FDA approval in November 2024.
0 jobs
Jobs
No jobs match — try clearing a filter.